| Name | Title | Contact Details |
|---|
Bloodstream infection leading to sepsis is responsible for more than half of all deaths in hospitals and is the most expensive condition treated in hospitals. Mortality rate increases 6% every hour from onset. Therefore, it is critical the right antibiotic treatment is determined quickly. Current methodologies require 3 days to determine the effective antibiotic. Specific Diagnostics has developed a new technology that determines the effective antibiotic in less than 1 day. Specific`s Reveal™ instrument and assay are cost effective and labor-saving allowing clinics to readily deploy the Specific Reveal solution. Specific`s unique patented technology leverages a low-cost small molecule sensor (SMS) array, enabling diagnostic products that simplify workflow and speed time-to-answer at low cost. Specific`s system streamlines lab workflow, reduce costs, and substantially shorten the time from sample arrival to selection of effective therapy, saving patients faced with fast-moving and deadly drug-resistant blood infections. Specific and its founders have written almost 60 peer-reviewed publications, detailing the successful demonstration of the SMS array technology. The Company itself has independently authored over 20 scientific publications and conference abstracts detailing the SMS array powered detection, identification and antibiotic susceptibility testing.
Kinetic Instruments is a Bethel, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
As the intraoperative imaging expert, IMRIS, Deerfield Imaging measurably improves patient outcomes through planning, product integration and clinical workflow to give surgeons access to diagnostic quality scans in operating room suites. The IMRIS Surgical Theatre, which uniquely transport MR and CT scanners to the patient using ceiling-mounted rails and incorporate other IMRIS imaging technology, are sold globally to hospitals that deliver clinical services to patients in neurosurgical, spinal, interventional and orthopedic markets.
Axonics Modulation Technologies, Inc is a privately-held medical device company developing an innovative neuromodulation platform based on a miniaturized rechargeable fully-implantable IPG licensed from the Alfred Mann Foundation. The Axonics Sacral Neuromodulation System is designed to improve the experience of both clinicians and patients suffering from Urinary and Fecal dysfunction.
Strategic Vision Inc is a Stedman, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.